Denali Advisors LLC Jazz Pharmaceuticals PLC Transaction History

Denali Advisors LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 Apr 26, 2021	SELL	$150.19 - $173.5 $2.16 Million - $2.5 Million	-14,400 Closed	0 $0
Q4 2020 Jan 20, 2021	SELL	$140.71 - $165.05 $422,130 - $495,150	-3,000 Reduced 17.24%	14,400 $2.38 Million
Q3 2020 Oct 16, 2020	SELL	$105.46 - $144.13 $1.01 Million - $1.38 Million	-9,600 Reduced 35.56%	17,400 $2.48 Million
Q2 2020 Jul 23, 2020	BUY	$95.68 - $121.88 $765,440 - $975,040	8,000 Added 42.11%	27,000 $2.98 Million
Q1 2020 Apr 23, 2020	BUY	$87.74 - $152.74 $1.67 Million - $2.9 Million	19,000 New	19,000 $1.9 Million
Q4 2019 Jan 30, 2020	SELL	$117.65 - $153.73 $458,835 - $599,547	-3,900 Closed	0 $0
Q3 2019 Oct 09, 2019	SELL	$125.18 - $143.24 $25,036 - $28,648	-200 Reduced 4.88%	3,900 $500,000
Q2 2019 Jul 08, 2019	BUY	$125.55 - $144.48 $514,755 - $592,368	4,100 New	4,100 $584,000

514

57.6M

188K

133K

Ticker JAZZ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,680,700
Market Cap $7.56B
Description
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...

Get notified when there are updates to the investment portfolio of Denali Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Denali Advisors LLC with notifications on news.